ReviewMycopathologia2014
Fungal endocarditis observed over an 8-year period and a review of the literature.
Review in Mycopathologia, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.
- Antifungal Efficacy of Amphotericin B in Candida Albicans Endocarditis Therapy: Systematic Review.Brazilian journal of cardiovascular surgery · 2020Pooled it
- Impact ofMolecular imaging and radionuclide therapy · 2026Article
- Synergistic eradication ofFrontiers in medicine · 2026Article
- Contemporary Cleveland Clinic experience of fungal infective endocarditis: a focus on imaging and outcomes.European heart journal. Imaging methods and practice · 2025Article
- Epidemiology, Risk Factors and Clinical Outcome of Candidaemia:Sultan Qaboos University medical journal · 2025Observational
- Favourable outcome ofSouthern African journal of infectious diseases · 2025Article
- Article
- Late Recurrence of Prosthetic Valve Endocarditis Due to Candida albicans.The American journal of case reports · 2024Article
- Gut microbiota and risk of endocarditis: a bidirectional Mendelian randomization study.Frontiers in microbiology · 2024Article
- Fungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management.Clinical microbiology reviews · 2023Review
- First case report ofFrontiers in cardiovascular medicine · 2023Article
- Endocarditis in Liver Transplant Recipients: A Systematic Review.Journal of clinical medicine · 2021Review
- Fatal native aortic valve fungal endocarditis caused byIDCases · 2021Article
- Case Report: Infective Endocarditis Caused byFrontiers in medicine · 2021Article
- Candida Endocarditis in Patients with Candidemia: A Single-Center Experience of 14 Cases.Mycopathologia · 2020Article
- Successful treatment of Aspergillus mural endocarditis in malignant lymphoma using a combined antifungal and surgical approach: a case report.Surgical case reports · 2020Article
- Fatal Prosthetic Valve Endocarditis Due toInfection and drug resistance · 2020Article
- Recurrent Endocarditis in Persons Who Inject Drugs.Open forum infectious diseases · 2019Article
- Article
- Aspergillus endocarditis of the mitral valve with ventricular myocardial invasion, cerebral vasculitis, and intracranial mycotic aneurysm formation in a patient with hemophagocytic lymphohistiocytosis.Medical mycology case reports · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFungal endocarditis (FE) is a "modern" disease that is considered an emerging cause of infective endocarditis (IE). The most frequently identified fungal pathogens are Candida spp., which are responsible for up to two-thirds of all cases; the remaining cases are due to Aspergillus spp., Histoplasma capsulatum or, more rarely, other yeasts and moulds.
objectivesTo describe the prevalence, clinical characteristics and outcome of FE diagnosed in a single tertiary centre and review the literature concerning FE. DESIGN AND
settingAn 8-year retrospective review of the case records of patients attending a single Italian University Centre and diagnosed as having definite or probable IE as defined by the modified Duke criteria.
resultsSix patients were identified from 229 episodes of IE: five cases involved a prosthetic valve, and one a native valve of an intravenous drug user. Five cases were caused by Candida spp. (two by C. albicans, one each by C. lusitaniae, C. dubliniensis and C. glabrata) and one by Aspergillus flavus. Three patients were treated by means of surgery plus antifungal therapy; two received antifungal therapy alone. Three patients survived, but only the patient with Aspergillus endocarditis was followed up for a long time.
conclusionsFE is difficult to diagnose but generally associated with healthcare infections. The optimal treatment is poorly characterised, and international collaborative studies are urgently needed to evaluate newer antifungal agents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.